Article

Kala Bio has launched 'Researgency', an on-premises AI infrastructure platform tailored for the biotech industry. The platform, developed in collaboration with Younet AI, allows firms to securely store sensitive biological data, addressing industry privacy concerns.

Kala Bio has obtained a 12-month exclusive license for Researgency, with plans to pilot the platform internally and subsequently offer it as a subscription service. This initiative aims to provide a data-sovereign solution that contrasts with centralized AI platforms, responding to the growing demand for secure AI deployments in regulated sectors. The biotech industry's AI spending is projected to reach $25 billion by 2030, highlighting the potential market for such infrastructure.